Fortis Healthcare Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹2,331Cr
- +17.3% YoY
- +7.6% QoQ
- Net profit
- ₹329Cr
- +70.5% YoY
- +23.2% QoQ
- Margin
- 24%
- +2 pp YoY
- +1 pp QoQ
Guidance rank: #26 of 34 in Healthcare Services
See the sector's top 10 — free with your mobile number.
The short version
Hospital business expects sustained revenue growth with H1 FY26 growth at ~18-19%, and similar momentum anticipated in H2 despite seasonal fluctuations. Hospital EBITDA margin target is around 25%, with current levels near 23%, indicating potential margin improvement in the next 2 years (Page 12).
From Fortis Healthcare Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Hospital business expects sustained revenue growth with H1 FY26 growth at ~18-19%, and similar momentum anticipated in H2 despite seasonal fluctuations.
- Anticipated 5-6% ARPOB (Average Revenue Per Occupied Bed) growth in H2 driven by mix changes like robotic surgeries and day care procedures; price hikes expected around 1-1.5%.
- Bed additions planned: around 400-plus beds organically in the current and next fiscal year, including 225 beds from FMRI and 70 beds in Kolkata.
- Diagnostics business revenue grew 7.3% in Q2 FY26, with expectations to continue positive growth momentum supported by new labs and expanded services.
2 more points from Fortis Healthcare Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Fortis Healthcare Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Fortis Healthcare is actively adding bed capacity, with about 400-plus beds added organically in the current year and a similar addition (300-400 beds range) expected in FY 2027.
- Major bed additions next year include 225 beds at FMRI and approximately 70 beds in Kolkata, along with ramp-up at Manesar and Bangalore facilities.
- They are open to greenfield hospital projects; current greenfield hospitals include FMRI Mohali, Ludhiana, Noida, and Shalimar Bagh. Future greenfield opportunities will be evaluated as appropriate.
- The company is pursuing brownfield expansions and inorganic growth opportunities, such as acquisitions (e.g., Shrimann Super speciality Hospital in Jalandhar).
2 more points from Fortis Healthcare Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Fortis Healthcare Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Fortis Healthcare Ltd said on order book & pipeline — free account, 30 seconds.
Fortis Healthcare Ltd — Quarterly revenue & net profit
Fortis Healthcare Ltd Q2 FY26 results — key figures
| ₹ Cr | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 2,331 | 1,988 | +17.3% | 2,167 | +7.6% |
| Operating profit (EBITDA) | 556 | 435 | +27.8% | 491 | +13.2% |
| Operating margin | 24% | 22% | +2 pp | 23% | +1 pp |
| Profit before tax | 425 | 261 | +62.8% | 351 | +21.1% |
| Net profit (PAT) | 329 | 193 | +70.5% | 267 | +23.2% |
| EPS (₹) | 4.26 | 2.34 | +82.1% | 3.45 | +23.5% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.7K Cr, net profit ₹320 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Fortis Healthcare's management said in earlier quarters
Others in Healthcare Services this season
- Maitreya Medicare (Q2 FY26)
23.92 crore (Page 26). Key investor presentation takeaways from Maitreya Medicare's Q2 FY26 investor presentation — and how it ranks against sector peers.
- Metropolis Healt (Q2 FY26)
Organic growth remains strong at around 12%, with no immediate price hikes planned. Key concall takeaways from Metropolis Healt's Q2 FY26 earnings call — and…
- 3B Blackbio (Q2 FY26)
Q2 FY 2025-26 sales: ₹3042.83 Lakh (including COVID sales ₹10.23 Lakh), up from ₹2457.55 Lakh in Q2 FY 2024-25. Key concall takeaways from 3B Blackbio DX Ltd's…
- Unihealth Hosp (Q2 FY26)
Nashik financial closure achieved via equity and bank debt (INR 22 crores from Bank of India). Key concall takeaways from Unihealth Hospitals Ltd's Q2 FY26…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Fortis Healthcare Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Fortis Healthcare Ltd Q2 FY26 results?
Hospital business expects sustained revenue growth with H1 FY26 growth at ~18-19%, and similar momentum anticipated in H2 despite seasonal fluctuations. Hospital EBITDA margin target is around 25%, with current levels near 23%, indicating potential margin improvement in the next 2 years (Page 12).
What is Fortis Healthcare Ltd share price analysis?
Fortis Healthcare Ltd currently shows a neutral. The stock trades at a P/E of 66.1 with a market cap of ₹69,834 Cr. Investors should review the full earnings analysis for detailed insights.
Is Fortis Healthcare Ltd planning capital expenditure?
Fortis Healthcare is actively adding bed capacity, with about 400-plus beds added organically in the current year and a similar addition (300-400 beds range) expected in FY 2027. - Major bed additions next year include 225 beds at FMRI and approximately 70 beds in Kolkata, along with ramp-up at Manesar and Bangalore facilities. - They are open to greenfield hospital projects; current greenfield hospitals include FMRI Mohali, Ludhiana, Noida, and Shalimar Bagh.
Keep Fortis Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
